These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3491182)

  • 1. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration.
    Volkow ND; Brodie JD; Wolf AP; Angrist B; Russell J; Cancro R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1199-1202. PubMed ID: 3491182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
    Buchsbaum MS; Potkin SG; Marshall JF; Lottenberg S; Teng C; Heh CW; Tafalla R; Reynolds C; Abel L; Plon L
    Neuropsychopharmacology; 1992 May; 6(3):155-63. PubMed ID: 1599606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of metabolic activity in the treatment of schizophrenia.
    Brodie JD; Christman DR; Corona JF; Fowler JS; Gomez-Mont F; Jaeger J; Micheels PA; Rotrosen J; Russell JA; Volkow ND
    Ann Neurol; 1984; 15 Suppl():S166-9. PubMed ID: 6611117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.
    Bartlett EJ; Wolkin A; Brodie JD; Laska EM; Wolf AP; Sanfilipo M
    Psychiatry Res; 1991 Oct; 40(2):115-24. PubMed ID: 1763142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional brain function in schizophrenia. I. A positron emission tomography study.
    Gur RE; Resnick SM; Alavi A; Gur RC; Caroff S; Dann R; Silver FL; Saykin AJ; Chawluk JB; Kushner M
    Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.
    Buchsbaum MS; Wu JC; DeLisi LE; Holcomb HH; Hazlett E; Cooper-Langston K; Kessler R
    Biol Psychiatry; 1987 Apr; 22(4):479-94. PubMed ID: 2882788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
    Szechtman H; Nahmias C; Garnett ES; Firnau G; Brown GM; Kaplan RD; Cleghorn JM
    Arch Gen Psychiatry; 1988 Jun; 45(6):523-32. PubMed ID: 2897836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in schizophrenic patients with and without neuroleptic medication.
    DeLisi LE; Holcomb HH; Cohen RM; Pickar D; Carpenter W; Morihisa JM; King AC; Kessler R; Buchsbaum MS
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):201-6. PubMed ID: 2859295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
    Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders.
    Buchsbaum MS; DeLisi LE; Holcomb HH; Cappelletti J; King AC; Johnson J; Hazlett E; Dowling-Zimmerman S; Post RM; Morihisa J
    Arch Gen Psychiatry; 1984 Dec; 41(12):1159-66. PubMed ID: 6334502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
    Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
    Buchsbaum MS; Haier RJ; Potkin SG; Nuechterlein K; Bracha HS; Katz M; Lohr J; Wu J; Lottenberg S; Jerabek PA
    Arch Gen Psychiatry; 1992 Dec; 49(12):935-42. PubMed ID: 1360198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.
    Buchsbaum MS; Potkin SG; Siegel BV; Lohr J; Katz M; Gottschalk LA; Gulasekaram B; Marshall JF; Lottenberg S; Teng CY
    Arch Gen Psychiatry; 1992 Dec; 49(12):966-74. PubMed ID: 1449383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography.
    Gur RE; Resnick SM; Gur RC; Alavi A; Caroff S; Kushner M; Reivich M
    Arch Gen Psychiatry; 1987 Feb; 44(2):126-9. PubMed ID: 3492983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.